XM does not provide services to residents of the United States of America.

Australia shares post weekly loss as China's stimulus dampens mining appetite



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Australia shares post weekly loss as China's stimulus dampens mining appetite</title></head><body>

Benchmark index down 0.2% for week

Mining stocks post worst week in over 2 years

Energy sub-index declines by 2.1%

Updates to close

By Rishav Chatterjee

Nov 15 (Reuters) -Australian shares rose on Friday but ended the week marginally lower as miners slumped, reflecting dampened investor appetite after the country's top trading partner China unveiled its latest stimulus package.

The S&P/ASX 200 index .AXJO ended the session up 0.7% to 8,279.2 points, led by banking stocks as the local central bank continued to point towards high inflation, scrapping any expectations of an early rate cut.

However, the benchmark ended the week 0.2% lower.

"Wages are slowing and selling prices dropped; but given productivity remains weak, CPI outcomes remain more important, and the RBA still thinks underlying inflation remains too high," UBS said, holding on to 25 basis points cut estimate in May.

Financials .AXFJ ended the session up 1.4% and rose 2% for the week, bucking the broader trend of weekly declines.

Mining stocks .AXMM dropped 1.5% for the day and 7.1% for the week, their worst since June 2022, dragged by declines in iron ore prices.

BHP BHP.AX, Rio Tinto RIO.AX and Fortescue FMG.AX lost between 7.6% and 9.5% for the week.

Investors have been moving out of mining and energy stocks through the week, as concerns around China's $1.40 trillion stimulus package unveiled over the last weekend were compounded by Donald Trump winning the U.S. presidential election.

"U.S. tariffs on Australian goods are not expected to significantly impact the economy but a sharp decline in Chinese growth on the back of escalating trade tensions would be more harmful," said brokerage Jarden.

Energy shares .AXEJ closed down 2.1% for the week, as investors read through OPEC's downside revision for demand growth, a stronger U.S. dollar and the Chinese stimulus.

Woodside WDS.AX and Santos STO.AX dropped 0.2% and 0.9% for the week.

Healthcare stocks .AXHJ also fell after Trump picked Robert F. Kennedy Jr., an environmental activist who has spread misinformation on vaccines, to lead his health agency.

New Zealand's benchmark S&P/NZX 50 index .NZ50 ended almost flat.



Reporting by Rishav Chatterjee in Bengaluru; Editing by Varun H K

For more information on DIARIES & DATA:
U.S. earnings diary RESF/US
Wall Street Week Ahead .N/O
Global Economy Week Ahead DATA/
................................................................
For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.